Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Hui Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Special Medicine, Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Lung cancer is a fatal disease with the highest worldwide morbidity and mortality rates. Despite recent advances in targeted therapy and immune checkpoint inhibitors for cancer, their efficacy remained limited. Therefore, we designed a Newcastle disease virus (NDV)‐modified tumor whole‐cell vaccine as a therapeutic vaccine and identified its antigen presentation level to develop effective immunotherapy. Then, we calculated the therapeutic and immune‐stimulating effects of NDV‐modified lung cancer cell vaccine and intratumoral NDV injection combination on tumor‐bearing mice. The results showed that the immunogenic cell death (ICD) expression in NDV‐modified lung cancer cell vaccine stimulates dendritic cell maturation and T cell activation in vivo and in vitro. Moreover, NDV‐modified lung cancer cell vaccine combined with intratumoral NDV injection could significantly inhibit tumor growth and enhance the differentiation of Th1 cells and Inflammatory cell infiltration in vivo, leading to an excellent immunotherapeutic effect. Therefore, our results revealed that NDV‐modified lung cancer cell vaccine combined with intratumoral NDV injection could promote antigen presentation and induce a strong antitumor immune response, which provided a promising combined therapy strategy for tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Special Medicine, Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital, Dazhou, Sichuan, China.
- Research, Institute of Biopharmaceutical, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Immunology, College of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
ORCID-Profile: Hui Wang
Zitieren
APA
Wang, H., Nan, F., Zeng, Z., Zhang, X., Ke, D., Zhang, S., Zhou, X., Niu, D., Fan, T., Jiang, S., Zhang, X., Wang, Y., Wang, B., & Zhang, W. (2023). Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer. Journal of Medical Virology. https://doi.org/10.1002/jmv.28554
Vancouver
Wang H, Nan F, Zeng Z, Zhang X, Ke D, Zhang S, et al. Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer. Journal of Medical Virology. 2023. doi:10.1002/jmv.28554
BibTeX
@article{Wang2023,
author = {Wang, Hui and Nan, Fulong and Zeng, Zhou and Zhang, Xueming and Ke, Dingxin and Zhang, Shuyun and Zhou, Xiaoqiong and Niu, Delei and Fan, Tianyu and Jiang, Shasha and Zhang, Xianjuan and Wang, Yunyang and Wang, Bin and Zhang, Wanming},
title = {Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28554}
}
EUVIMED